Skip to main content


Follicular Lymphoma

Featured

News
For the first-line treatment of FL, obinutuzumab plus chemotherapy is cost-effective in comparison with rituximab-abbs or rituximab-pvvr plus chemotherapy in the United States.
Guideline Updates
NCCN released an update to its clinical practice guideline for B-cell lymphomas, featuring updates for follicular…
Quiz
True or False: The addition of rituximab to anthracycline-based chemotherapy improves PFS and OS in FL.
Conference Coverage
Rituximab monotherapy improves time-to-next treatment (TTNT) compared with observation in patients with advanced stage…
Conference Coverage
The addition of rituximab to anthracycline-based chemotherapy demonstrates improved PFS and OS in FL, according to a 35…
Back to Top